STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 93 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,000 | -37.5% | 1,120 | +41.8% | 0.00% | -100.0% |
| Q4 2018 | $8,000 | +700.0% | 790 | +777.8% | 0.00% | – |
| Q1 2018 | $1,000 | -80.0% | 90 | -73.8% | 0.00% | – |
| Q4 2017 | $5,000 | +150.0% | 344 | +45.1% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 237 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | -80.0% | 237 | -74.2% | 0.00% | -100.0% |
| Q4 2016 | $10,000 | – | 918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |